InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,734.22
(
-0.07%
)
US TECH 100
19,446.80
(
-0.12%
)
Dow Jones
42,165.21
(
-0.35%
)
Brent Oil
71.58
(
-0.17%
)
Bitcoin
63,489.25
(
-3.26%
)
Post# of 253255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 25
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: DewDiligence post# 150356

Wednesday, 10/10/2012 5:42:38 PM

Wednesday, October 10, 2012 5:42:38 PM

Post# of 253255
THis is one of three collabarative prevention trials.

this one is called DIAN and is using Gantenerumab, Solanezumab, and LY2886721

The one announced several months ago is called API, and is using crenezumab

The last one left, which is probably the most significant is called A4. They have yet to announce, but i have to think 1 of the 4 above will be included. All of the JNJ/PFE AIP products are virtually dead
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up